France will introduce in 2026 a “fast-track” pathway aimed at accelerating the authorisation of certain mono-national clinical trials. Reserved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback